Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rhinoplasty | 1 | 2023 | 10 | 0.860 |
Why?
|
| Facial Injuries | 2 | 2013 | 13 | 0.860 |
Why?
|
| Nose Neoplasms | 1 | 2023 | 17 | 0.850 |
Why?
|
| Pemphigoid, Bullous | 1 | 2020 | 3 | 0.680 |
Why?
|
| Neutrophils | 1 | 2020 | 365 | 0.560 |
Why?
|
| Skin | 1 | 2020 | 359 | 0.550 |
Why?
|
| Craniosynostoses | 1 | 2016 | 11 | 0.530 |
Why?
|
| Plagiocephaly, Nonsynostotic | 1 | 2016 | 4 | 0.530 |
Why?
|
| Craniofacial Abnormalities | 1 | 2016 | 26 | 0.530 |
Why?
|
| Melanoma | 1 | 2020 | 318 | 0.520 |
Why?
|
| Orthopedic Procedures | 1 | 2016 | 41 | 0.520 |
Why?
|
| Craniocerebral Trauma | 1 | 2016 | 56 | 0.510 |
Why?
|
| Facial Bones | 1 | 2013 | 10 | 0.430 |
Why?
|
| Skull Fractures | 1 | 2013 | 21 | 0.420 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2013 | 50 | 0.420 |
Why?
|
| Fracture Fixation, Internal | 1 | 2013 | 50 | 0.410 |
Why?
|
| Perioperative Care | 1 | 2013 | 76 | 0.410 |
Why?
|
| Intercellular Junctions | 1 | 2012 | 8 | 0.400 |
Why?
|
| Surgical Wound Infection | 1 | 2013 | 111 | 0.390 |
Why?
|
| Ear, Middle | 1 | 2012 | 21 | 0.390 |
Why?
|
| Ion Channels | 1 | 2012 | 88 | 0.380 |
Why?
|
| Hypopharynx | 1 | 2009 | 4 | 0.330 |
Why?
|
| Homeostasis | 1 | 2012 | 347 | 0.330 |
Why?
|
| Video-Assisted Surgery | 1 | 2009 | 10 | 0.320 |
Why?
|
| Laryngoscopes | 1 | 2009 | 22 | 0.320 |
Why?
|
| Foreign Bodies | 1 | 2009 | 45 | 0.310 |
Why?
|
| Laryngoscopy | 1 | 2009 | 61 | 0.310 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 739 | 0.280 |
Why?
|
| Postoperative Complications | 1 | 2013 | 1217 | 0.270 |
Why?
|
| Tranexamic Acid | 1 | 2024 | 6 | 0.230 |
Why?
|
| Antifibrinolytic Agents | 1 | 2024 | 15 | 0.230 |
Why?
|
| Blood Loss, Surgical | 1 | 2024 | 59 | 0.230 |
Why?
|
| Food Analysis | 1 | 2004 | 31 | 0.230 |
Why?
|
| Nutritional Sciences | 1 | 2004 | 31 | 0.230 |
Why?
|
| Sunscreening Agents | 1 | 2024 | 21 | 0.220 |
Why?
|
| Protective Clothing | 1 | 2024 | 28 | 0.220 |
Why?
|
| Mohs Surgery | 1 | 2024 | 52 | 0.220 |
Why?
|
| Nose | 1 | 2023 | 28 | 0.210 |
Why?
|
| Schools | 1 | 2024 | 150 | 0.210 |
Why?
|
| Skin Neoplasms | 2 | 2024 | 398 | 0.200 |
Why?
|
| Surgical Flaps | 1 | 2023 | 113 | 0.190 |
Why?
|
| Humans | 15 | 2024 | 59744 | 0.190 |
Why?
|
| Dapsone | 1 | 2020 | 8 | 0.170 |
Why?
|
| Drug Eruptions | 1 | 2020 | 14 | 0.170 |
Why?
|
| Prednisone | 1 | 2020 | 85 | 0.170 |
Why?
|
| Antimalarials | 1 | 2020 | 67 | 0.160 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 452 | 0.150 |
Why?
|
| Viral Load | 2 | 2009 | 220 | 0.150 |
Why?
|
| Glucocorticoids | 1 | 2020 | 181 | 0.150 |
Why?
|
| HIV Infections | 3 | 2009 | 915 | 0.150 |
Why?
|
| Orthotic Devices | 1 | 2016 | 10 | 0.130 |
Why?
|
| Treatment Outcome | 2 | 2020 | 5334 | 0.130 |
Why?
|
| Access to Information | 1 | 2016 | 30 | 0.130 |
Why?
|
| Language | 1 | 2016 | 133 | 0.120 |
Why?
|
| Accountable Care Organizations | 1 | 2016 | 66 | 0.120 |
Why?
|
| HIV-1 | 2 | 2010 | 692 | 0.110 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 605 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 943 | 0.110 |
Why?
|
| Fracture Fixation | 1 | 2013 | 16 | 0.110 |
Why?
|
| Fracture Healing | 1 | 2013 | 24 | 0.110 |
Why?
|
| Injury Severity Score | 1 | 2013 | 102 | 0.100 |
Why?
|
| Plasma | 2 | 2010 | 35 | 0.100 |
Why?
|
| Medicaid | 1 | 2016 | 353 | 0.100 |
Why?
|
| Wound Healing | 1 | 2013 | 179 | 0.100 |
Why?
|
| Radiography | 1 | 2013 | 519 | 0.090 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 444 | 0.090 |
Why?
|
| Male | 3 | 2020 | 27952 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 870 | 0.090 |
Why?
|
| Blood | 1 | 2010 | 29 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 857 | 0.080 |
Why?
|
| Aged | 2 | 2020 | 13513 | 0.080 |
Why?
|
| HIV Reverse Transcriptase | 1 | 2009 | 10 | 0.080 |
Why?
|
| Blood Preservation | 1 | 2009 | 4 | 0.080 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2009 | 28 | 0.080 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2009 | 23 | 0.080 |
Why?
|
| Specimen Handling | 1 | 2010 | 61 | 0.080 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2009 | 90 | 0.080 |
Why?
|
| HIV | 1 | 2009 | 68 | 0.080 |
Why?
|
| Prognosis | 1 | 2013 | 1613 | 0.080 |
Why?
|
| Radiography, Thoracic | 1 | 2009 | 111 | 0.080 |
Why?
|
| Drug Resistance, Viral | 1 | 2010 | 156 | 0.070 |
Why?
|
| Equipment Design | 1 | 2009 | 334 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 534 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2013 | 2387 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2013 | 1935 | 0.070 |
Why?
|
| Hemostasis, Surgical | 1 | 2024 | 17 | 0.060 |
Why?
|
| Administration, Topical | 1 | 2024 | 48 | 0.060 |
Why?
|
| Nutritional Requirements | 1 | 2004 | 20 | 0.060 |
Why?
|
| Injections, Subcutaneous | 1 | 2024 | 70 | 0.060 |
Why?
|
| Sunburn | 1 | 2024 | 11 | 0.060 |
Why?
|
| Computers | 1 | 2004 | 49 | 0.060 |
Why?
|
| Nutrition Policy | 1 | 2004 | 39 | 0.060 |
Why?
|
| Postoperative Hemorrhage | 1 | 2024 | 38 | 0.060 |
Why?
|
| Sunlight | 1 | 2024 | 29 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2009 | 2354 | 0.050 |
Why?
|
| Students | 1 | 2004 | 202 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2013 | 6156 | 0.050 |
Why?
|
| Health Promotion | 1 | 2004 | 471 | 0.040 |
Why?
|
| Mice | 1 | 2012 | 10317 | 0.040 |
Why?
|
| Temperature | 2 | 2010 | 299 | 0.040 |
Why?
|
| United States | 2 | 2024 | 7448 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 1104 | 0.030 |
Why?
|
| Adult | 2 | 2009 | 15771 | 0.030 |
Why?
|
| Child | 1 | 2024 | 4215 | 0.030 |
Why?
|
| Animals | 1 | 2012 | 19705 | 0.030 |
Why?
|
| Adolescent | 1 | 2024 | 5866 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2016 | 514 | 0.020 |
Why?
|
| Female | 1 | 2013 | 30926 | 0.020 |
Why?
|
| Medicare | 1 | 2016 | 601 | 0.020 |
Why?
|
| Humidity | 1 | 2010 | 12 | 0.020 |
Why?
|
| Desiccation | 1 | 2010 | 6 | 0.020 |
Why?
|
| Hematologic Tests | 1 | 2010 | 15 | 0.020 |
Why?
|
| Paper | 1 | 2010 | 13 | 0.020 |
Why?
|
| Genotype | 1 | 2010 | 621 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2009 | 646 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 1988 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2009 | 621 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 1570 | 0.020 |
Why?
|
| Time Factors | 1 | 2010 | 3629 | 0.010 |
Why?
|
| Mutation | 1 | 2009 | 2462 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 4290 | 0.010 |
Why?
|